Supporting Your Business in the US

Stepoutside Consulting is a provider of business services to European biotechnology companies and is focused on the execution of business development projects in the U.S.
The young “start-up” culture in the European biotech sector has created innovative technologies and services, with many companies that have products at or near launch. To sell and market these products beyond local markets is costly, time-consuming and risky. Therefore, establishing a representation in new markets can be a challenge for companies with limited resources. Outsourcing provides a powerful and effective alternative while minimizing the risks.

Stepoutside Consulting offers a complete, time- and cost-effective solution to business development needs of small life science and biotechnology companies with little or no business capacity in the U.S. The company’s consultants and independent partners have extensive knowledge and experience from pharma-and biotech industries. Services include:
Local representation
Sales and marketing
Financing
Regulatory
Operations and planning
Strategy and technology
Alliances and partnerships
Human resources
Complete marketentry support
The company’s existing knowledge and understanding of the U.S. market translates into an immediate business development capacity for the U.S. for its clients. The elimination of the need for a full-time U.S. operation for clients leads to cost reductions. Depending on their needs, the company represents its clients on a flexible schedule. It limits the risks by providing complete market entry plans and offering market analyses to assess the value of entering the U.S. market. Access to the company’s extensive scientific and corporate networks allows clients to profit from new sales and marketing channels and provides the opportunity to create new alliances, partnerships and collaborations. A new line of products targets clients with an interest in financing opportunities via US investors. It includes writing and review of company documentaton and introductions to selected investors.